Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients.

Objective: Mometasone furoate (MF) is a new, potent synthetic inhaled corticosteroid. Worldwide, MF is administered via a dry-powder inhaler that contains multiple doses. As a preparation that would be more cost-effective, single-dose MF capsules were developed in Brazil.